Research and Markets: Market Research: Lysosomal Storage Disorder - Pipeline Review, H2 2013
Health-care stocks are on a tear as demand slowly returns.
Use this screen to find high-growth businesses that have big ideas to keep competitors at bay.
With two years of stellar returns behind us, our expectations for 2013 are more muted, but some opportunities persist.
The five biotech ETFs have very different portfolios with markedly different performance.
While we remain bullish on the sector, health-care growth depends on the economy.